Xbrane Biopharma
Develops affordable biosimilars for serious diseases using patented, high-yield production tech.
XBRANE | ST
Overview
Corporate Details
- ISIN(s):
- SE0007789409 (+1 more)
- LEI:
- 5493008DKD05APTKQO39
- Country:
- Sweden
- Address:
- RETZIUS VÄG, 8, 171 65 Solna
- Website:
- https://xbrane.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Xbrane Biopharma is a biotechnology company specializing in the development of biosimilars, which are affordable, follow-on versions of approved biological drugs. The company's mission is to increase global access to treatments for serious diseases such as cancer, rheumatoid arthritis, and macular degeneration. Xbrane leverages a patented, high-yield production platform technology designed to significantly reduce manufacturing costs, aiming for up to an 80% cost reduction compared to standard systems. Its development portfolio includes biosimilar candidates targeting major biologic drug markets, such as Xlucane™ (a ranibizumab biosimilar) and BIIB801 (an adalimumab biosimilar).
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Xbrane Biopharma and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-10 08:30 |
Pre-Annual General Meeting Information
NOTICE OF EXTRA GENERAL MEETING IN XBRANE BIOPHARMA AB
|
English | 78.5 KB | |
| 2025-09-10 08:30 |
Pre-Annual General Meeting Information
KALLELSE TILL EXTRA BOLAGSSTÄMMA I XBRANE BIOPHARMA AB
|
Swedish | 77.2 KB | |
| 2025-08-26 08:00 |
Interim Report
|
Swedish | 1.3 MB | |
| 2025-08-26 08:00 |
Interim Report
|
English | 1.3 MB | |
| 2025-07-31 21:00 |
Share Issue/Capital Change
Xbrane Biopharma AB ("Xbrane" eller "Bolaget") har enligt tidigare offentliggjo…
|
Swedish | 64.5 KB | |
| 2025-07-31 21:00 |
Share Issue/Capital Change
Xbrane Biopharma AB (“Xbrane” or the “Company”) has according to previously ann…
|
English | 64.3 KB | |
| 2025-07-16 12:24 |
Major Shareholding Notification
|
Swedish | 10.1 KB | |
| 2025-07-11 08:30 |
Prospectus
Xbrane publishes disclosure document regarding admission to trading of the newl…
|
English | 80.6 KB | |
| 2025-07-11 08:30 |
Share Issue/Capital Change
Xbrane offentliggör undantagsdokument avseende upptagande till handel av de nye…
|
Swedish | 72.9 KB | |
| 2025-07-03 11:00 |
Post-Annual General Meeting Information
Kommuniké från extra bolagsstämma i Xbrane Biopharma AB
|
Swedish | 62.1 KB | |
| 2025-07-03 11:00 |
Share Issue/Capital Change
Announcement from extra general meeting in Xbrane Biopharma AB
|
English | 62.4 KB | |
| 2025-06-10 05:15 |
Pre-Annual General Meeting Information
KALLELSE TILL EXTRA BOLAGSSTÄMMA I XBRANE BIOPHARMA AB
|
Swedish | 69.0 KB | |
| 2025-06-10 05:15 |
Pre-Annual General Meeting Information
NOTICE OF EXTRA GENERAL MEETING IN XBRANE BIOPHARMA AB
|
English | 70.2 KB | |
| 2025-06-10 05:00 |
Share Issue/Capital Change
Xbrane har, villkorat av godkännande av en extra bolagsstämma, beslutat att gen…
|
Swedish | 98.9 KB | |
| 2025-06-10 05:00 |
Share Issue/Capital Change
Xbrane has, subject to the approval by an EGM, resolved to carry out an oversub…
|
English | 99.5 KB |
Automate Your Workflow. Get a real-time feed of all Xbrane Biopharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Xbrane Biopharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-17 | Karl Martin Erik Åmark | Other | Buy | 1,864,223 | 318,782.13 SEK |
| 2025-01-17 | Karl Martin Erik Åmark | Other | Sell | 1,864,223 | 315,053.69 SEK |
| 2025-01-16 | Siavash Bashiri | Other | Sell | 1,519,932 | 260,212.36 SEK |
| 2025-01-16 | Siavash Bashiri | Other | Buy | 1,500,000 | 256,500.00 SEK |
| 2023-09-12 | Karl Martin Erik Åmark | Other | Buy | 4,000 | 129,000.00 SEK |
| 2023-09-12 | Karl Martin Erik Åmark | Other | Sell | 4,000 | 128,200.00 SEK |
| 2023-09-11 | Karl Martin Erik Åmark | Other | Sell | 2,000 | 62,140.00 SEK |
| 2023-09-08 | Siavash Bashiri | Other | Sell | 5,890 | 194,959.00 SEK |
| 2023-09-08 | Karl Martin Erik Åmark | Other | Other | 4,320 | 968.54 SEK |
| 2023-09-08 | Karl Martin Erik Åmark | Other | Other | 4,320 | N/A |
